Recent progress in the understanding and treatment of transthyretin amyloidosis [PDF]
Yoshiki Sekijima
openalex +1 more source
Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance [PDF]
Tomonori Ishii +6 more
openalex +1 more source
Transthyretin Amyloid Cardiomyopathy: The Plot Thickens as Novel Therapies Emerge. [PDF]
Dimza M, Vasilakis G, Grodin JL.
europepmc +1 more source
Phenotypic Characterization of Cardiac Involvement in Carriers With Pathogenic TTR Variants Warrants an Evidence-Based Approach. [PDF]
Muller SA +4 more
europepmc +1 more source
Circulating transthyretin with atrial morpho-functional phenotypes and atrial fibrillation risk, and the modifying role of BMI. [PDF]
Zhang N +9 more
europepmc +1 more source
'Masked apical sparing' in wild-type transthyretin cardiac amyloidosis complicated by aortic valve stenosis: a case report. [PDF]
Matsumoto K, Matsuo K, Arai T, Nakano S.
europepmc +1 more source
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial [PDF]
Karola Jering +12 more
openalex +1 more source
Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis [PDF]
Diana Michels da Silva +2 more
openalex +1 more source
Misdiagnosis of 99mTc-PYP-positive Danon disease as ATTR-CA: a case report and molecular imaging pitfalls. [PDF]
Xie LJ, Chen XZ, Zhong JL, Xie XJ.
europepmc +1 more source

